Specialty code 183500000X · Sacramento, CA
NPI
1396142436
Since 2014
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1650 Response Rd, Clinical Pharmacy Operations
Sacramento, CA, 95815
Phone (916) 614-4589
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$6.4M
630 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug George J David prescribed most often to Medicare patients was Abiraterone Acetate, with 200 prescriptions and refills. In total George J David wrote 630 Medicare prescriptions that cost $6.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Abiraterone Acetate Generic | 200 | 205 | 63 | $29K |
| Tagrisso Osimertinib Mesylate | 59 | 59 | 18 | $1.1M |
| Brukinsa Zanubrutinib | 42 | 42 | 12 | $528K |
| Cabometyx Cabozantinib S-Malate | 38 | 38 | 13 | $825K |
| Ibrance Palbociclib | 28 | 28 | Under 11 | $438K |
| Imatinib Mesylate Generic | 23 | 24 | Under 11 | $1,114 |
| Kisqali Ribociclib Succinate | 19 | 19 | Under 11 | $314K |
| Mekinist Trametinib Dimethyl Sulfoxide | 18 | 18 | Under 11 | $268K |
| Truqap Capivasertib | 17 | 17 | Under 11 | $410K |
| Lynparza Olaparib | 16 | 16 | Under 11 | $270K |
| Everolimus Generic | 14 | 14 | Under 11 | $5,274 |
| Pazopanib Hcl Generic | 13 | 13 | Under 11 | $52K |
| Tafinlar Dabrafenib Mesylate | 12 | 12 | Under 11 | $173K |
| Sprycel Dasatinib | 11 | 11 | Under 11 | $111K |
Brand drugs: 366 claims; generic drugs: 264 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to George J David were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.